Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.69
+0.62 (12.23%)
At close: Aug 28, 2026, 4:00 PM EDT
5.65
-0.04 (-0.70%)
After-hours: Aug 28, 2026, 7:46 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $97.75 million as of August 28, 2026. Its market cap has increased by 82.71% in one year.
Market Cap
97.75M
Enterprise Value
88.36M
1-Year Change
82.71%
Ranking
Category
Stock Price
$5.69
ChartMarket Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $97.75M, a decrease of -77.61%. That is a compound annual growth rate of -16.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 97.70M | 23.83% |
| Dec 31, 2025 | 78.90M | 147.34% |
| Dec 31, 2024 | 31.90M | -89.64% |
| Dec 29, 2023 | 307.90M | 172.48% |
| Dec 30, 2022 | 113.00M | -55.18% |
| Dec 31, 2021 | 252.10M | -15.32% |
| Dec 31, 2020 | 297.70M | -27.32% |
| Dec 31, 2019 | 409.60M | 95.61% |
| Dec 31, 2018 | 209.40M | -52.04% |
| Jun 15, 2018 | 436.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 104.90M |
| Yarrow Bioscience | 103.60M |
| PolyPid | 102.98M |
| Polaryx Therapeutics | 102.68M |
| Adicet Bio | 97.52M |
| Cognition Therapeutics | 97.00M |
| Kalaris Therapeutics | 95.93M |
| Pelthos Therapeutics | 94.68M |